PMC:7344504 / 4233-4730 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T10","span":{"begin":252,"end":256},"obj":"Body_part"},{"id":"T11","span":{"begin":264,"end":269},"obj":"Body_part"},{"id":"T12","span":{"begin":306,"end":317},"obj":"Body_part"}],"attributes":[{"id":"A10","pred":"fma_id","subj":"T10","obj":"http://purl.org/sig/ont/fma/fma74402"},{"id":"A11","pred":"fma_id","subj":"T11","obj":"http://purl.org/sig/ont/fma/fma9670"},{"id":"A12","pred":"fma_id","subj":"T12","obj":"http://purl.org/sig/ont/fma/fma54878"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T7","span":{"begin":264,"end":269},"obj":"Body_part"},{"id":"T8","span":{"begin":306,"end":317},"obj":"Body_part"}],"attributes":[{"id":"A7","pred":"uberon_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"A8","pred":"uberon_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/UBERON_0001728"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"122","span":{"begin":186,"end":196},"obj":"Species"},{"id":"123","span":{"begin":361,"end":368},"obj":"Species"},{"id":"124","span":{"begin":57,"end":68},"obj":"Chemical"},{"id":"125","span":{"begin":35,"end":55},"obj":"Disease"}],"attributes":[{"id":"A122","pred":"tao:has_database_id","subj":"122","obj":"Tax:2697049"},{"id":"A123","pred":"tao:has_database_id","subj":"123","obj":"Tax:9606"},{"id":"A124","pred":"tao:has_database_id","subj":"124","obj":"MESH:D002738"},{"id":"A125","pred":"tao:has_database_id","subj":"125","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T29","span":{"begin":35,"end":43},"obj":"Disease"},{"id":"T30","span":{"begin":46,"end":55},"obj":"Disease"},{"id":"T31","span":{"begin":186,"end":194},"obj":"Disease"}],"attributes":[{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T28","span":{"begin":204,"end":205},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T29","span":{"begin":252,"end":256},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T30","span":{"begin":264,"end":269},"obj":"http://purl.obolibrary.org/obo/UBERON_0000178"},{"id":"T31","span":{"begin":264,"end":269},"obj":"http://www.ebi.ac.uk/efo/EFO_0000296"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T30","span":{"begin":57,"end":68},"obj":"Chemical"}],"attributes":[{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"LitCovid-sentences","denotations":[{"id":"T37","span":{"begin":0,"end":181},"obj":"Sentence"},{"id":"T38","span":{"begin":182,"end":263},"obj":"Sentence"},{"id":"T39","span":{"begin":264,"end":356},"obj":"Sentence"},{"id":"T40","span":{"begin":357,"end":437},"obj":"Sentence"},{"id":"T41","span":{"begin":438,"end":497},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}

{"project":"2_test","denotations":[{"id":"32517166-31992387-60114384","span":{"begin":258,"end":260},"obj":"31992387"}],"text":"Because of the high probability of SARS-CoV-2 infection, chloroquine treatment was started (600 mg and 300 mg on day 1, 300 mg q12h days 2–5), which was national policy at the time. The SARS-CoV-2 PCR of a nasopharyngeal swab was positive (Ct 30.59; E gene [12]). Blood cultures remained negative, as were nasopharynx bacterial cultures taken at admission. The patient was subsequently admitted to our general inpatient respiratory ward. An overview of her hospital course is depicted in Figure 2."}